Skip to content

A Comparative Study of Percutaneous Single Air Endoscopic Intervertebral Plate Removal and Archaeal Microscopic Intervertebral Plate

Evaluation of the efficacy and safety of conventional microscopic discectomy and interlaminar full-endoscopic discectomy to treat lumbar herniated intervertebral disc (ENDO-F Trial): A prospective, randomized, Assessor blind, multicenter trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006227
Enrollment
100
Registered
2021-06-08
Start date
2021-06-15
Completion date
Unknown
Last updated
2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery, Others(interlaminar full-endoscopic discectomy, conventional microscopic discectomy ) : 1) Percutaneous single-hole endoscopic intervertebral disc removal Intervertebral plate resec

Sponsors

The Catholic University of Korea, Daejeon St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. 20 to 80 years old B. Patients with lateral or bilateral lower extremity radiology with intervertebral disc herniation can be examined for at least one year. C. A person who has signed a consent form after fully understanding the details of the clinical trial by himself (only if signature is available) or his/her legal representative; D. Payroll recognition target

Exclusion criteria

Exclusion criteria: A. Meyer Gr II+ Spondylostasis B. A person who previously performed the same segment surgery C. Lumbar degenerative scoliosis (Cobbangle> 20 degrees) D. Lumbar intervertebral disc exodus If there are other spinal problems in the affected area (such as ankylosing spondylitis, tumor, compression fracture, etc.) E. Psychiatric disorders (dementia, mental retardation, severe drug addiction, etc.) F. Who refused to participate in the study G. Other patients deemed inappropriate by the person in charge of clinical trials for clinical trials

Design outcomes

Primary

MeasureTime frame
Difference in ODI value after 52 weeks after surgery

Secondary

MeasureTime frame
Oswestry disability index(ODI) score changes;Visual Analogue Scale(VAS) score changes;Walking time;Satisfaction after surgery;Period to return to daily life;POSAS questionnaire;Radiological evaluation

Countries

Korea, Republic of

Contacts

Public ContactHong jae Lee

The Catholic University of Korea, Daejeon St. Mary's Hospital

lhjoc9506@naver.com+82-42-220-9251

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026